Investment analysis, share recommendations, and market insights.
Here are two Australian medical device companies doing impressive things in the medical imaging area in Australia and the US.
After the US stock market delivering big time for two years, the big question is, should long-term investors at least do a partial rotation into European or Japanese stocks via quality ETFs?
In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities explains why he considers Macquarie Group (MQG) as a BUY.
If you’re looking for capital growth, it can be quite rewarding to take a flutter on the more speculative end of the market, using funds you can afford to lose. Here are two of those stocks but remember the risk!
I agree with Shane Oliver that while a correction is highly likely this year, we’ll see a positive year for remaining long the share market. But you’ll need to pivot, take profit in some stocks and get exposed to different investments bound to benefit from rate cuts.
We’ve made some changes to our portfolios for 2025 to consider the dominant investment themes we expect to apply. We have also rebalanced the portfolios.
In our “HOT STOCK” column today, Raymond Chan, Head of Asian Desk at Morgan’s explains why he likes RIO.
In our “HOT STOCK” column today, Michael Gable, MD of Fairmont Equities, explains why he believes CBA will continue to trend higher from here and make new highs.
Here are three stocks I like, but that have blotted their copybooks recently.
I’ve been sifting through the market dogs of 2024 for overlooked sector and stock gems. Here are two sector and stock ideas for contrarians:
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.